Ketamine-Induced Blood Pressure Lowering in the Rat

흰쥐에서 Ketamine에 의한 혈압하강

  • Yu Xian-Feng (College of Veterinary Medicine, Chonbuk National University) ;
  • Kim Shang-Jin (College of Veterinary Medicine, Chonbuk National University) ;
  • Lee Mun-Young (College of Veterinary Medicine, Chonbuk National University) ;
  • Kang Hyung-Sub (Bio-safety Research Institute, Center for Healthcare Technology Development, Chonbuk National University) ;
  • Kim Jin-Shang (Bio-safety Research Institute, Chonbuk National University)
  • 유선봉 (전북대학교 수의과대학) ;
  • 김상진 (전북대학교 수의과대학) ;
  • 이문영 (전북대학교 수의과대학) ;
  • 강형섭 (전북대학교 생체안전성연구소, 헬스케어 기술개발 사업단) ;
  • 김진상 (전북대학교 생체안전성연구소)
  • Published : 2005.09.01

Abstract

Although ketamine has been used in the field of anesthetic medicine for its safety and favourable respiratory effects, the cardiovascular effects of ketamine is still controversial. To clarify the action and mechanism of ketamine upon cardiovascular system, arterial blood pressure, tension of aortic ring, left ventricular developed pressure and heart rate were measured in rats, Ketamine produced two types of effects on arterial blood pressure in anesthetized rats; monophasic effect (blood pressure lowering) and biphasic effect (initial transient blood pressure increasing following sustained lowering), The ketamine-induced lowering of aterial blood pressure showed a concentration-dependent manner, inhibited by the pretreament of $MgCl_2$ and potentiated by the pretreatment of $CaCl_2$. The ketamine-induced lowering of aterial blood pressure was suppressed by the pretreatment of nifedipine, verapamil or lidocaine. In phenylephrine-precontracted endothelium intact (+E) aortic rings, ketamine sometimes caused a small enhancement of contraction ($112.5{\pm}3.6{\%}$). However, in many experiments, ketamine produced a concentration-dependent relaxation in +E aortic rings precontracted with either phenylephrine or KCl. Ketamine-induced relaxation was significantly greater in KCl-precontracted strips than phenylephrine-precontracted strips. In phenylephrine-precontracted +E aortic rings, the ketamine-induced vasorelaxation was not suppressed by endothelium removal or by the pretreatment of a nitric oxide synthase inhibitors, L-$N^G$-nitro-arginine and a guanylate cyclase inhibitors, methylene blue, suggesting that the ketamine-induced vasorelaxation is not dependent on the endothelial function. In addition, ketamine elicited an increase in left ventricular developed pressure in perfused hearts accompanied by decrease in heart rate. These results suggest that ketamine could evoke a hypotension due to vasorelaxation and decrease in heart rate in rats. The inhibitory effect of cardiovascular system might be associated with modulation of $Ca^{2+}$ homeostasis.

Keywords

References

  1. Altura BM, Altura BT, Carella A. Effects of ketamine on vascular smooth muscle function. Br J Pharmacol 1980; 70: 257-267 https://doi.org/10.1111/j.1476-5381.1980.tb07931.x
  2. Benham CD, Tsien RW. A novel receptor-operated $Ca^{2+}$-permeable channel activated by ATP in smooth muscle. Nature 1987; 328: 275-278 https://doi.org/10.1038/328275a0
  3. Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP. Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol 2000; 184: 409-420 https://doi.org/10.1002/1097-4652(200009)184:3<409::AID-JCP16>3.0.CO;2-K
  4. Cauvin C, Loutzenhiser R, Van Breemen C. Mechanism of calcium-antagonist induced vasodilation. Annu Rev Pharmacol 1983; 23: 373-396 https://doi.org/10.1146/annurev.pa.23.040183.002105
  5. Clanachan AS, McGrath lC. Effects of ketamine on peripheral autonomic nervous system of the rat. Br J Pharmac 1976; 58: 247-252 https://doi.org/10.1111/j.1476-5381.1976.tb10402.x
  6. Clanachan AS, McGrath JC, Machenzie JE. Cardiovascular effects of ketamine in the pithed rat, rabbit and cat. Br J Anaesth 1976; 48: 935-939 https://doi.org/10.1093/bja/48.10.935
  7. Churchill-Davidson HC. A practice of anesthesia, 5th ed. Chicago: Yearbook Medical Publisher. 1984: 636
  8. Corssen G, Domino EF. Dissociative anesthesia; Further pharmacologic studies and first clinical experience with the phencycline derivative CI-581. Anesth Analg Curr Res 1966; 45: 29-40
  9. Dart AM, Kingwell BA. Pulse pressure-a review of mechanisms and clinical relevance. J Am Coll Caridiol 2001; 37: 975-984 https://doi.org/10.1016/S0735-1097(01)01108-1
  10. Diaz FA, Bianco JA, Bello A, Beer N, Velarde H, Izquierdo JP, Jaen R. Effect of ketamine on canine cardiovascular function. Brit J Anesth 1976; 48: 941-946 https://doi.org/10.1093/bja/48.10.941
  11. Domino EF, Chodoff P, Corssen G. Pharmacological effects of CI-581, a new dissociative anesthetic in man. Cli Pharmacol Ther 1965; 6: 279-291
  12. Donald C. Plumb, Pharm D. Veterinary drug handbook. Veterinary Teaching Hospitals, College of Veterinary Medicine University of Minnesota 2002: 463
  13. Dowdy EG, kaya K. Studies of the mechanism of cardiovascular response to CI-581. Anesthesiology 1968; 29: 931-943 https://doi.org/10.1097/00000542-196809000-00014
  14. Dripps RD, Eckenhoff JE, Vandam LD. Introduction to anesthesia, 6th ed. Philadelphia: WB Saunders. 1982: 155
  15. Fukuda S, Murakawa T, Takeshita H, Toda N. Direct effects of ketamine on isolated canine cerebral and nesenteric arteries. Anesth Analg 1983; 62: 553-558
  16. Fukuda S, Su C, Lee TJ. Potentiation of pressor responses to serotonin by ketamine in isolated perfused rat mesentery. J Cardiovasc Pharmacol 1986; 8: 756-770
  17. Goldberg AH, Klane PW, Phear WPC. Effects of ketamine on contractile performance and excitability of isolated heart muscle. J Pharmacol Exp Ther 1970; 175: 388-394
  18. Hudgins PM, Weiss GB. Differential effects of calcium removal upon vascular smooth muscle contraction induced by norepinephrine, histamine and potassium. J Pharmacol Exp Ther 1968; 159: 91-97
  19. Idvall J, Ahlgren I, Aronsen KF. Ketamine infusion: Pharmacokinetics and clinical effects. Br J Anesth 1979; 51: 1167-1173 https://doi.org/10.1093/bja/51.12.1167
  20. Iseri LT, French JH. Magnesium: nature's physiological calcium blocker. Am Heart J 1984; 108: 188-193 https://doi.org/10.1016/0002-8703(84)90572-6
  21. Ivankovich AD, Miletich DJ, Reinamm C, Albrecht RF, Zahed B. Cardiovascular effcts of centrally administered ketamine in goats. Anesth Analg 1974; 53: 924-933 https://doi.org/10.1213/00000539-197453060-00022
  22. Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, Miyamoto S, Nakazawa H, Won KJ, Sato K. Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev 1997; 49: 157-230
  23. Kohrs R, Durieux ME. Ketamine: teaching an old drug new tricks. Anesth Analg 1998, 87: 1186-1193, 1998 https://doi.org/10.1097/00000539-199811000-00039
  24. Lehot JJ, Bastien O, Pelissier FT, Villard J, Estanove S. Vascular effects of ketamine during anesthesia with diazepam and fentanyl. Ann Fr Anesth Reanim 1992; 11: 8-11 https://doi.org/10.1016/S0750-7658(05)80313-2
  25. Lundy PM, Gowdy CW, Colhoun FH. Tracheal smooth muscle relaxant effect of ketamine. Br J Anesth 1974; 46: 333 https://doi.org/10.1093/bja/46.5.333
  26. Laurant P, Dalle M, Berthelot A, Rayssiguier Y. Time-course of the change in blood pressure level in magnesium-deficient Wi star rats. Br J Nutr 1999; 82: 243-251
  27. Maducka AL, Hajghassemali M. Arterial blood gases in mothers and infants during ketamine anesthesia for surgical delivery. Anesth Analg 1978; 57: 121-123
  28. McCarthy DA, Chen G, Kamump DH, Ensor C. General anesthetic and other pharmacological properties of 2-(Ochloropheny-2-methylamino-cyclo-hexanone HCI (CI-581). J New Drugs 1965; 5: 21-33 https://doi.org/10.1002/j.1552-4604.1965.tb00219.x
  29. McGrath JC, MacKenzie JE, Miller RA. Circulatory responses to ketamine: dependence on respiratoly pattern and background anesthesia in the rabbit. Brit J Anesth 1975; 47: 1149-1156 https://doi.org/10.1093/bja/47.11.1149
  30. McGrath JC, MacKenzie JE. The effects of intravenous anaesthetics on the cardiovascular system of the rabbit. Br J Pharmacol 1977; 61: 199-212 https://doi.org/10.1111/j.1476-5381.1977.tb08405.x
  31. Miller RD, Anesthesia, 2nd ed. New York: Churchill-Livingstone. 1986: 815
  32. Murasato Y, Harada Y, Ikeda M, Nakashima Y, Hayashida Y. Effect of magnesium deficiency on autonomic circulatory regulation in conscious rats. Hypertension 1999; 34: 247-252 https://doi.org/10.1161/01.HYP.34.2.247
  33. Nakajima T, Hazama H, Hamada E, Wu SN, Igarashi K, Yamashita T, Seyama Y, Omata M, Kurachi Y. Endothelin-l and vasopressin activate $Ca^{2+}$-permeable non-selective cation channels in aortic smooth muscle cells: mechanism of receptor-mediated $Ca^{2+}$ influx. J Mol Cell Cardiol 1996; 28: 707-722 https://doi.org/10.1006/jmcc.1996.0066
  34. Ochsner AJ. Cardiovascular and respiratory responses to ketamine hydrochloride in the rhesus minkey (macaca mulatta). Lab Animal Sci 1977; 27: 69-71
  35. Oh SS, Lee SW, Kang HS, Kim JS. Magnesium-induced vasorelaxation effects and blood pressure lowering. Kor J Vet Res 2003; 43: 373-382
  36. Rusy BF, Amuzu JK, Bosscher HA, Redon D, Komai H. Negative inotropic effect of ketamine in rabbit ventricular muscle. Anesth Analg 1990; 71: 275-278
  37. Schwartz DA, Horwitz LD. Effects of ketamine on left ventricular performance. J Pharmacol Exp Ther 1975; 194: 410-414
  38. Shirahata M, Okada Y, Minomiya I. Efeect of ketamine on renal nerve activity, Arterial pressure and heart rates in rats. Jap J Physiol 1983; 33: 391-401 https://doi.org/10.2170/jjphysiol.33.391
  39. Somlyo, AP, Himpens B. Cell calcium and its regulation in smooth muscle. FASEB J 1989; 3: 2266-2276
  40. Sjogren A, Edvinsson L and Fallgren B. Magnesium deficiency in coronary artery disease and cardiac arrhythmias. J Intern Med 1989; 226: 213-222 https://doi.org/10.1111/j.1365-2796.1989.tb01383.x
  41. Traber DL, Wilson RD, Priano LL. Differentiation of the cardiovascular effects of CI-581. Anesth Analg 1968; 47: 769-777
  42. Traber DL, Wilson RD. Involvement of the sympathetic nervous system and pressor responses to ketamine. Anesth Analg 1969; 48: 248-252
  43. Traber DL, Wilson RD, Priano LL. The effect of beta-adrenergic blockade on the cardiopulmonary response to ketamine. Anesth Analg 1970; 49: 604-613
  44. Tweed WA, Minuck M, Mymin D. Circulatory responses to ketamine anesthesia. Anesthesiology 1972; 37: 613-619 https://doi.org/10.1097/00000542-197212000-00008
  45. Urthaler F, Walker AA, James TN. Comparison of the inotropication of morphine and ketamine studies in canine cardiac muscle. J Thor Cardiovasc Surg 1976; 72: 142-149
  46. White PF, Ham J, Way WL, Trevor AJ. Pharmacology of ketamine isomers in surgical patients. Anesthesiology 1980; 52: 231 https://doi.org/10.1097/00000542-198003000-00008
  47. White PF, Way WL, Trevor AJ. Ketamine-its pharmacology and therapeutic uses. Anesthesiology 1982; 56: 119-136 https://doi.org/10.1097/00000542-198202000-00007
  48. Wyte SR, Shapiro HM, Turner P, Harris AB. Ketamine-induced intracranial hypertension. Anesthesiology 1972; 36: 174-176 https://doi.org/10.1097/00000542-197202000-00021